Company intelligence / Profile preview

Zoi Capital

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Zoi Capital is not a drug or device developer and does not have its own clinical programs or results. It is an investment firm focusing on early- to mid-stage digital health and artificial intelligence (AI) healthcare companies, supporting digital health platform development, patient engagement, decentralized recruitment, and real-world data analysis. Its proprietary AI Doc platform, which uses a knowledge management database and specialized scorecards, helps systematically identify and support high-potential health AI companies and applications.

Industry: Investors

Beyond the preview

Go deeper on Zoi Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zoi Capital.

Explore the full profile